Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics, Treatment Patterns, and Clinical Outcomes of Chronic Hepatitis B Across 3 Continents: Retrospective Database Study.
Gillespie IA, Chan KA, Liu Y, Hsieh SF, Schindler C, Cheng W, Chang R, Kap E, Morais E, Duh MS, Park S, Ketz M, Jenner S, Boxall N, Kendrick S, Theodore D. Gillespie IA, et al. Among authors: theodore d. Adv Ther. 2023 Feb;40(2):425-444. doi: 10.1007/s12325-022-02284-1. Epub 2022 Nov 9. Adv Ther. 2023. PMID: 36350533 Free PMC article.
Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies.
Gillespie IA, Barnes E, Wong ICK, Matthews PC, Cooke GS, Tipple C, Elston RC, Liu Y, Smith DA, Wang T, Davies J, Várnai KA, Freeman O, Man KKC, Lau WCY, Glampson B, Meng X, Morais E, Liu S, Mercuri L, Boxall N, Jenner S, Kendrick S, Dong J, Theodore D. Gillespie IA, et al. Among authors: theodore d. Infect Dis Ther. 2023 Nov;12(11):2513-2532. doi: 10.1007/s40121-023-00824-y. Epub 2023 Jul 11. Infect Dis Ther. 2023. PMID: 37432642 Free PMC article.
Correction to: Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies.
Gillespie IA, Barnes E, Wong ICK, Matthews PC, Cooke GS, Tipple C, Elston RC, Liu Y, Smith DA, Wang T, Davies J, Várnai KA, Freeman O, Man KKC, Lau WCY, Glampson B, Meng X, Morais E, Liu S, Mercuri L, Boxall N, Jenner S, Kendrick S, Dong J, Theodore D. Gillespie IA, et al. Among authors: theodore d. Infect Dis Ther. 2023 Nov;12(11):2533-2534. doi: 10.1007/s40121-023-00857-3. Infect Dis Ther. 2023. PMID: 37759129 Free PMC article. No abstract available.
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B.
Buti M, Heo J, Tanaka Y, Andreone P, Atsukawa M, Cabezas J, Chak E, Coffin CS, Fujiwara K, Gankina N, Gordon SC, Janczewska E, Komori A, Lampertico P, McPherson S, Morozov V, Plesniak R, Poulin S, Ryan P, Sagalova O, Sheng G, Voloshina N, Xie Q, Yim HJ, Dixon S, Paff M, Felton L, Lee M, Greene T, Lim J, Lakshminarayanan D, McGonagle G, Plein H, Youssef AS, Elston R, Kendrick S, Theodore D. Buti M, et al. Among authors: theodore d. J Hepatol. 2024 Aug 29:S0168-8278(24)02488-7. doi: 10.1016/j.jhep.2024.08.010. Online ahead of print. J Hepatol. 2024. PMID: 39214467 Free article.
Comparison of Pharmacokinetics of the GalNAc-Conjugated Antisense Oligonucleotide GSK3389404 in Participants with Chronic Hepatitis B Infection across the Asia-Pacific Region.
Han K, Ito H, Elston R, Cremer J, Hood S, Paff M, Theodore D. Han K, et al. Among authors: theodore d. Antimicrob Agents Chemother. 2023 Jan 24;67(1):e0090022. doi: 10.1128/aac.00900-22. Epub 2022 Dec 12. Antimicrob Agents Chemother. 2023. PMID: 36507675 Free PMC article. Clinical Trial.
Efficacy and Safety of Bepirovirsen in Hepatitis B. Reply.
Yuen MF, Elston R, Theodore D. Yuen MF, et al. Among authors: theodore d. N Engl J Med. 2023 Mar 23;388(12):1147-1148. doi: 10.1056/NEJMc2216469. N Engl J Med. 2023. PMID: 36947478 No abstract available.
Shaping the Future of Infectious Diseases: The Journey to Promote Value, Opportunity, and Positive Messaging.
Paras ML, Chirch LM, Aziz M, Balba GP, Benson C, Butt S, James SH, McCarty TP, Razonable R, Reece R, Shnekendorf R, Swartz TH, Viehman JA, Luther VP; Infectious Diseases Society of America Fellowship Training Program Directors Community of Practice and Working Group (complete list of contributing authors in the Working Group listed in acknowledgments). Paras ML, et al. Open Forum Infect Dis. 2024 Nov 12;11(12):ofae669. doi: 10.1093/ofid/ofae669. eCollection 2024 Dec. Open Forum Infect Dis. 2024. PMID: 39610405 Free PMC article.
Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study.
Shoemaker K, Soboleva K, Branche A, Shankaran S, Theodore DA, Bari M, Ezeh V, Green J, Kelly E, Lan D, Olsson U, Saminathan S, Shankar NK, Villegas B, Villafana T, Falsey AR, Sobieszczyk ME. Shoemaker K, et al. Among authors: theodore da. Vaccines (Basel). 2024 Aug 3;12(8):883. doi: 10.3390/vaccines12080883. Vaccines (Basel). 2024. PMID: 39204009 Free PMC article.
120 results